Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rare Diseases | 4 | 2024 | 48 | 2.070 |
Why?
|
| Genomics | 5 | 2024 | 101 | 1.910 |
Why?
|
| Intellectual Disability | 8 | 2024 | 35 | 1.140 |
Why?
|
| Genetic Testing | 3 | 2024 | 87 | 1.130 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 39 | 0.920 |
Why?
|
| Polycomb Repressive Complex 2 | 4 | 2022 | 7 | 0.910 |
Why?
|
| Rural Population | 1 | 2024 | 42 | 0.910 |
Why?
|
| Neurodevelopmental Disorders | 5 | 2024 | 23 | 0.850 |
Why?
|
| Humans | 23 | 2024 | 6896 | 0.770 |
Why?
|
| Nerve Tissue Proteins | 2 | 2023 | 26 | 0.760 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 14 | 0.710 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 14 | 0.710 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2024 | 99 | 0.690 |
Why?
|
| Hand Deformities, Congenital | 2 | 2020 | 2 | 0.690 |
Why?
|
| Congenital Hypothyroidism | 2 | 2020 | 4 | 0.690 |
Why?
|
| Craniofacial Abnormalities | 2 | 2020 | 10 | 0.680 |
Why?
|
| Growth Disorders | 2 | 2019 | 25 | 0.670 |
Why?
|
| Abnormalities, Multiple | 2 | 2020 | 36 | 0.660 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 81 | 0.660 |
Why?
|
| Hydrocephalus | 1 | 2018 | 8 | 0.640 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2018 | 5 | 0.640 |
Why?
|
| Equipment Failure | 1 | 2018 | 10 | 0.640 |
Why?
|
| Mutation | 3 | 2020 | 212 | 0.640 |
Why?
|
| Seizures | 1 | 2018 | 25 | 0.630 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2024 | 231 | 0.590 |
Why?
|
| Child | 11 | 2024 | 3364 | 0.570 |
Why?
|
| Male | 10 | 2024 | 3337 | 0.550 |
Why?
|
| Mosaicism | 2 | 2020 | 9 | 0.520 |
Why?
|
| Phenotype | 5 | 2024 | 257 | 0.510 |
Why?
|
| Child, Preschool | 8 | 2024 | 1569 | 0.480 |
Why?
|
| Lipomatosis | 1 | 2014 | 1 | 0.480 |
Why?
|
| Mesentery | 1 | 2014 | 1 | 0.480 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 8 | 0.480 |
Why?
|
| Autism Spectrum Disorder | 2 | 2024 | 32 | 0.440 |
Why?
|
| Female | 9 | 2024 | 3525 | 0.440 |
Why?
|
| Sequence Analysis, DNA | 3 | 2023 | 115 | 0.430 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 348 | 0.410 |
Why?
|
| Laboratories | 2 | 2022 | 14 | 0.400 |
Why?
|
| Mutation, Missense | 4 | 2022 | 28 | 0.380 |
Why?
|
| Genome, Human | 2 | 2022 | 86 | 0.380 |
Why?
|
| Gene Deletion | 2 | 2021 | 13 | 0.370 |
Why?
|
| DNA Methylation | 2 | 2023 | 115 | 0.370 |
Why?
|
| Megalencephaly | 2 | 2021 | 3 | 0.360 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 6 | 0.250 |
Why?
|
| Cohort Studies | 3 | 2024 | 289 | 0.240 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 4 | 0.240 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 17 | 0.240 |
Why?
|
| Transcription Factors | 5 | 2023 | 52 | 0.240 |
Why?
|
| Haploinsufficiency | 2 | 2023 | 10 | 0.230 |
Why?
|
| Drosophila Proteins | 1 | 2024 | 8 | 0.230 |
Why?
|
| Medicine | 1 | 2023 | 10 | 0.220 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2022 | 1 | 0.220 |
Why?
|
| Insurance Coverage | 1 | 2023 | 21 | 0.210 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 43 | 0.210 |
Why?
|
| Autistic Disorder | 1 | 2022 | 14 | 0.200 |
Why?
|
| Genome | 1 | 2022 | 32 | 0.200 |
Why?
|
| Pedigree | 1 | 2022 | 59 | 0.200 |
Why?
|
| Repressor Proteins | 1 | 2021 | 12 | 0.190 |
Why?
|
| Skull | 1 | 2021 | 12 | 0.190 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 9 | 0.190 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2020 | 1 | 0.180 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 2 | 0.180 |
Why?
|
| Heart | 1 | 2020 | 14 | 0.180 |
Why?
|
| Adult | 3 | 2024 | 1181 | 0.170 |
Why?
|
| Neural Crest | 1 | 2020 | 51 | 0.160 |
Why?
|
| Language Disorders | 1 | 2018 | 1 | 0.160 |
Why?
|
| Speech Disorders | 1 | 2018 | 3 | 0.160 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 2 | 0.160 |
Why?
|
| DNA Helicases | 1 | 2018 | 5 | 0.160 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 2 | 0.160 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 99 | 0.160 |
Why?
|
| Membrane Proteins | 3 | 2022 | 54 | 0.150 |
Why?
|
| Time Factors | 1 | 2018 | 250 | 0.150 |
Why?
|
| Infant | 3 | 2020 | 1446 | 0.150 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 130 | 0.140 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 42 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 77 | 0.120 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 1 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2014 | 27 | 0.120 |
Why?
|
| Exome | 2 | 2023 | 36 | 0.110 |
Why?
|
| Alleles | 2 | 2024 | 214 | 0.100 |
Why?
|
| Animals | 2 | 2024 | 729 | 0.100 |
Why?
|
| DNA Copy Number Variations | 2 | 2022 | 37 | 0.100 |
Why?
|
| Adolescent | 3 | 2024 | 2197 | 0.100 |
Why?
|
| Neoplasm Proteins | 2 | 2020 | 31 | 0.090 |
Why?
|
| Neural Stem Cells | 1 | 2024 | 7 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2024 | 15 | 0.060 |
Why?
|
| Penetrance | 1 | 2024 | 8 | 0.060 |
Why?
|
| beta Catenin | 1 | 2024 | 9 | 0.060 |
Why?
|
| Neurons | 1 | 2024 | 19 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2024 | 59 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 5 | 0.060 |
Why?
|
| Drosophila | 1 | 2024 | 7 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2024 | 6 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 21 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2024 | 190 | 0.060 |
Why?
|
| North America | 1 | 2023 | 44 | 0.060 |
Why?
|
| Mice | 1 | 2024 | 348 | 0.060 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2023 | 1 | 0.060 |
Why?
|
| Base Sequence | 1 | 2023 | 81 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2024 | 174 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2022 | 1 | 0.050 |
Why?
|
| Zinc | 1 | 2022 | 2 | 0.050 |
Why?
|
| Research Design | 1 | 2023 | 63 | 0.050 |
Why?
|
| Haplotypes | 1 | 2023 | 91 | 0.050 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2022 | 3 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2022 | 4 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 18 | 0.050 |
Why?
|
| Exons | 1 | 2022 | 34 | 0.050 |
Why?
|
| Fetal Hemoglobin | 1 | 2021 | 1 | 0.050 |
Why?
|
| Lymphoid Tissue | 1 | 2021 | 3 | 0.050 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2021 | 1 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2021 | 2 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 39 | 0.050 |
Why?
|
| Heterozygote | 1 | 2021 | 26 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 99 | 0.050 |
Why?
|
| Data Accuracy | 1 | 2021 | 6 | 0.050 |
Why?
|
| Reference Values | 1 | 2021 | 39 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 53 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 199 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 3 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2018 | 3 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2018 | 14 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2018 | 32 | 0.040 |
Why?
|
| Gene Expression | 1 | 2018 | 67 | 0.040 |
Why?
|
| Young Adult | 1 | 2020 | 647 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 410 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2019 | 816 | 0.030 |
Why?
|